Comparison
2q13 Microdeletion Syndrome C6012360 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 2q13 Microdeletion Syndrome and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Chromosomal change | A small missing segment of chromosome 2 is described. | A small extra segment of chromosome 14 is described. | High |
| Developmental features | Development may be affected; a specific pattern is not established. | Developmental delay may occur, but features vary. | Low |
| Reported severity and onset | Labeled severe, with variable onset. | Labeled moderate, with onset described from 0 to 5 years. | Moderate |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
A confirmed loss at 2q13
The chromosomal result, not symptoms alone, distinguishes the condition.
High
Recognition at a variable age
The supplied onset is variable rather than restricted to early childhood.
Low
Substantial multispecialty needs
The source describes symptom-based care for a severe congenital condition.
Moderate
Choose 14q11 2 Microduplication Syndrome C4749855 when
A confirmed gain at 14q11.2
Diagnosis requires the specified duplication and clinical correlation.
High
Features identified from birth through age 5
This matches the supplied onset range, without proving the diagnosis.
Moderate
A variable phenotype needing support
The source emphasizes supportive therapy and monitoring.
Moderate
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss involving 2q13. | May show copy-number gain involving 14q11.2. | Region, size, genes, and clinical context require specialist interpretation; no cutoff is supplied. |
| Karyotype | A small deletion may not be visible. | A small duplication may not be visible. | A normal karyotype does not exclude either condition. |
| Targeted confirmation | An appropriate assay may confirm a 2q13 loss. | An appropriate assay may confirm a 14q11.2 gain. | Method selection depends on the laboratory and initial finding. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; the source labels it severe and chronic.
- Factors
- Deletion content, associated findings, and available support may matter, but specifics are not supplied.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Outcome is not established; the source labels it moderate, early-onset, and chronic.
- Factors
- Duplication content and developmental needs may matter, but exact predictors are not supplied.
Time frame: Both are lifelong congenital conditions; precise milestones are not established.
Confirmed genetic findings and individual clinical assessment outweigh the category label.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible, but the pattern is not established. Delay may occur; its range is not established. Supplied sources do not define complication rates or severity. |
| Physical differences | Distinctive features are mentioned without specifics. Features are described as variable. A shared or characteristic phenotype should not be assumed. |
| Ongoing care needs | Multiple specialists may be involved according to symptoms. Supportive therapies and monitoring are emphasized. Care is individualized; no treatment doses are established here. |
Patient education highlights
- HighMeaning of the result
A chromosomal finding needs genetics review and does not by itself predict every symptom.
- HighTransmission to contacts
Neither condition is communicable. Inheritance questions require individual genetic counseling.
- MediumVariable course
Symptoms and outcomes can differ; the supplied data do not establish prognosis.